Omnia Biologics, Inc.
Omnia Biologics Expands on Drug Development Cost-Management Services
Published in Gene Therapy Weekly, April 23rd, 2009
“Omnia understands that much of the overhead associated with drug development requires the application of assets having high fixed and overhead costs,” said Dale VanderPutten, Ph.D., Chief Executive Officer of Omnia. “We have built our business model recognizing these costs are a strain for many firms. Outsourcing non-core activities reduces the risk drug developers face while allowing them to manage cash, contain costs, focus on core strengths, maintain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-04-23)
More Articles from Gene Therapy Weekly
- Research
Biomarker associated with poor outcome in aggressive childhood cancer - Cancer
Research on cancer reported by G.R. Deng et al - Cancer
Research reports on cancer from University of Cincinnati provide new insights - Cancer Vaccines
Study results from L. Aurisicchio and colleagues broaden understanding of cancer vaccines - Cardiology
New findings in cardiology described from Ohio State University - Fabry Disease
New fabry disease study findings have been reported by K.M. Aakre and co-researchers - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
